Literature DB >> 14999708

The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.

Sophie Le Calvez, Dominique Thabut, Djamila Messous, Mona Munteanu, Vlad Ratziu, Francoise Imbert-Bismut, Thierry Poynard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14999708     DOI： 10.1002/hep.20099

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  19 in total

1.  Prognostic value of liver fibrosis biomarkers: a meta-analysis.

Authors:  Thierry Poynard; Yen Ngo; Hugo Perazzo; Mona Munteanu; Pascal Lebray; Joseph Moussalli; Dominique Thabut; Yves Benhamou; Vlad Ratziu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-07

2.  Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.

Authors:  M V Ragni; C G Moore; K Soadwa; M A Nalesnik; A B Zajko; A Cortese-Hassett; T L Whiteside; S Hart; A Zeevi; J Li; O S Shaikh
Journal:  Haemophilia       Date:  2010-08-16       Impact factor: 4.287

3.  Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C.

Authors:  Agostino Colli; Alice Colucci; Silvia Paggi; Mirella Fraquelli; Sara Massironi; Marco Andreoletti; Vittorio Michela; Dario Conte
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

4.  Clinical Utility of Biomarkers of Liver Fibrosis.

Authors:  Keyur Patel; Don C Rockey
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

Review 5.  Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

Authors:  Giada Sebastiani; Alfredo Alberti
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

6.  Role of simple biomarkers in predicting fibrosis progression in HCV infection.

Authors:  Rajasekhara R Mummadi; John R Petersen; Shu-Yuan Xiao; Ned Snyder
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

7.  Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C.

Authors:  A K P Lim; S D Taylor-Robinson; N Patel; R J Eckersley; R D Goldin; G Hamilton; G R Foster; H C Thomas; D O Cosgrove; M J K Blomley
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

8.  Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics.

Authors:  Libang Yang; Kyle D Rudser; LeeAnn Higgins; Hugo R Rosen; Atif Zaman; Christopher L Corless; Larry David; Glenn R Gourley
Journal:  Dig Dis Sci       Date:  2011-05-17       Impact factor: 3.199

9.  Comparison of liver biopsy and transient elastography based on clinical relevance.

Authors:  Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Erik Goto; Takahisa Sato; Takamasa Ohki; Tadashi Goto; Hideo Yoshida; Fumihiko Kanai; Yosuke Sugioka; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Journal:  Can J Gastroenterol       Date:  2008-09       Impact factor: 3.522

10.  Assessment of liver fibrosis: noninvasive means.

Authors:  Thierry Poynard; Rachel Morra; Patrick Ingiliz; Françoise Imbert-Bismut; Dominique Thabut; Djamila Messous; Mona Munteanu; Julien Massard; Yves Benhamou; Vlad Ratziu
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.